BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 16595374)

  • 21. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deregulated expression of CD40 ligand in HTLV-I infection: distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients.
    Harhaj NS; Janic B; Ramos JC; Harrington WJ; Harhaj EW
    Virology; 2007 May; 362(1):99-108. PubMed ID: 17258259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Kodama D; Saito M; Matsumoto W; Sabouri AH; Izumo S; Arimura K; Usuku K; Bangham CR; Osame M
    J Neuroimmunol; 2004 Nov; 156(1-2):188-94. PubMed ID: 15465610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection.
    Abdelbary NH; Abdullah HM; Matsuzaki T; Hayashi D; Tanaka Y; Takashima H; Izumo S; Kubota R
    J Infect Dis; 2011 Apr; 203(7):948-59. PubMed ID: 21402546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An altered peptide ligand antagonizes antigen-specific T cells of patients with human T lymphotropic virus type I-associated neurological disease.
    Kubota R; Soldan SS; Martin R; Jacobson S
    J Immunol; 2000 May; 164(10):5192-8. PubMed ID: 10799878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation.
    Grant C; Barmak K; Alefantis T; Yao J; Jacobson S; Wigdahl B
    J Cell Physiol; 2002 Feb; 190(2):133-59. PubMed ID: 11807819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct evidence for a chronic CD8+-T-cell-mediated immune reaction to tax within the muscle of a human T-cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis.
    Ozden S; Cochet M; Mikol J; Teixeira A; Gessain A; Pique C
    J Virol; 2004 Oct; 78(19):10320-7. PubMed ID: 15367598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of valproate on Tax and HBZ expression in HTLV-1 and HAM/TSP T lymphocytes.
    Belrose G; Gross A; Olindo S; Lézin A; Dueymes M; Komla-Soukha I; Smadja D; Tanaka Y; Willems L; Mesnard JM; Peloponese JM; Césaire R
    Blood; 2011 Sep; 118(9):2483-91. PubMed ID: 21505188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
    Parker CE; Daenke S; Nightingale S; Bangham CR
    Virology; 1992 Jun; 188(2):628-36. PubMed ID: 1374983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HTLV-1 Tax-Specific CTL Epitope-Pulsed Dendritic Cell Therapy Reduces Proviral Load in Infected Rats with Immune Tolerance against Tax.
    Ando S; Hasegawa A; Murakami Y; Zeng N; Takatsuka N; Maeda Y; Masuda T; Suehiro Y; Kannagi M
    J Immunol; 2017 Feb; 198(3):1210-1219. PubMed ID: 28011931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
    Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; Weber JN; Bangham CR
    Blood; 2000 Feb; 95(4):1386-92. PubMed ID: 10666215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.
    Curis C; Percher F; Jeannin P; Montange T; Chevalier SA; Seilhean D; Cartier L; Couraud PO; Gout O; Gessain A; Ceccaldi PE; Afonso PV
    J Virol; 2016 Aug; 90(16):7303-7312. PubMed ID: 27252538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection.
    Rahman S; Khan ZK; Wigdahl B; Jennings SR; Tangy F; Jain P
    J Immunol; 2011 Jan; 186(1):390-402. PubMed ID: 21115731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.
    Greten TF; Slansky JE; Kubota R; Soldan SS; Jaffee EM; Leist TP; Pardoll DM; Jacobson S; Schneck JP
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7568-73. PubMed ID: 9636190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T-lymphotropic virus type 1-infected cells secrete exosomes that contain Tax protein.
    Jaworski E; Narayanan A; Van Duyne R; Shabbeer-Meyering S; Iordanskiy S; Saifuddin M; Das R; Afonso PV; Sampey GC; Chung M; Popratiloff A; Shrestha B; Sehgal M; Jain P; Vertes A; Mahieux R; Kashanchi F
    J Biol Chem; 2014 Aug; 289(32):22284-305. PubMed ID: 24939845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
    Höger TA; Jacobson S; Kawanishi T; Kato T; Nishioka K; Yamamoto K
    J Immunol; 1997 Aug; 159(4):2042-8. PubMed ID: 9257872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.
    Tanaka Y; Sato T; Yagishita N; Yamauchi J; Araya N; Aratani S; Takahashi K; Kunitomo Y; Nagasaka M; Kanda Y; Uchimaru K; Morio T; Yamano Y
    Front Immunol; 2022; 13():993025. PubMed ID: 36081501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
    Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
    J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.